Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival
Objectives The advent of the tyrosine kinase inhibitors has markedly changed the prognostic outlook for patients with Ph + and/or BCR-ABL1 + chronic myeloid leukemia (CML). This study was designed to assess the overall survival (OS) of Nigerian patients with CML receiving imatinib therapy and to ide...
Main Authors: | Anthony A. Oyekunle, Muheez A. Durosinmi, Ramoni A. Bolarinwa, Temilola Owojuyigbe, Lateef Salawu, Norah O. Akinola |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-01-01
|
Series: | Clinical Medicine Insights: Blood Disorders |
Online Access: | https://doi.org/10.4137/CMBD.S31562 |
Similar Items
-
Chronic Myeloid Leukemia in Nigerian Patients: Anemia is an Independent Predictor of Overall Survival
by: Anthony A. Oyekunle, et al.
Published: (2016-06-01) -
Determinants of Overall and Progression-Free Survival of Nigerian Patients with Philadelphia-Positive Chronic Myeloid Leukemia
by: Anthony A. Oyekunle, et al.
Published: (2015-01-01) -
Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia with e1a3 BCR-ABL1 transcript in a Nigerian with sickle cell anemia: a case report
by: Ibrahim O. Ahmed, et al.
Published: (2021-10-01) -
Burkitt Lymphoma: A Potentially Curable Childhood Tumour: Experience in Ile-Ife, Nigeria (1986-2014)
by: Durosinmi Muheez A
Published: (2016-06-01) -
Challenges to Care and Medication Adherence of Patients With Chronic Myeloid Leukemia in a Resource Limited Setting
by: R A Bolarinwa MBChB, MSc, FMCPath, et al.
Published: (2018-09-01)